Floatz logo

Mecobalamin

Amyotrophic Lateral Sclerosis (ALS)

Eisai Co., Ltd.Phase 2/3Dormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
81/ 100

Competitive context

151 Active assets in the Amyotrophic Lateral Sclerosis (ALS) cohort.

Asset / SponsorPhaseRating
TAURURSODIOL
Amylyx Pharmaceuticals Inc.
Phase 3BBB
Tofersen
Biogen
Phase 4BBB
Riluzole
AB Science
Phase 4BB
Mexiletine
Bjorn Oskarsson, MD
Phase 4BB
DIACETYL(N(4)-METHYLTHIOSEMICARBAZONATO) COPPER (II)
Collaborative Medicinal Development Pty Limited
Phase 2/3BB

View all 50 →

Same molecule, other indications

Mecobalamin is also rated in:

chemotherapy-induced neuropathyDormant
B
Indicative ·
61 / 100
View asset →
hand-foot syndromeDormant
B
Indicative ·
60 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →